Recombinant Human Apolipoprotein A II/ApoA-II (ab192286) is not available
The apoB/apoA-I Ratio is a Strong Predictor of Cardiovascular Risk | IntechOpen
Apolipoprotein A-I-containing lipoproteins with pre-beta electrophoretic mobility.
An apoA-I mimetic peptide facilitates off-loading cholesterol from HDL to liver cells through scavenger receptor BI
apoA-V Antibody (A-12) | SCBT - Santa Cruz Biotechnology
Effect of apoA-I PEGylation on the Biological Fate of Biomimetic High-Density Lipoproteins | ACS Omega
The association of apolipoproteins with later-life all-cause and cardiovascular mortality: a population-based study stratified by age | Scientific Reports
IVD Antibody Development Services for ApoA, B, E Markers - Creative Biolabs
Initial interaction of apoA-I with ABCA1 impacts in vivo metabolic fate of nascent HDL - ScienceDirect
Apolipo proteins
The Central Helices of ApoA-I Can Promote ATP-binding Cassette Transporter A1 (ABCA1)-mediated Lipid Efflux - Journal of Biological Chemistry
Apolipoproteins in vascular biology and atherosclerotic disease | Nature Reviews Cardiology
Heterozygosity for apolipoprotein A-I(R160L)Oslo is associated with low levels of high density lipoprotein cholesterol and HDL-s
Scientists identify marker that predicts changes in cholesterol levels as people grow older. - Healthinnovations- Latest Innovative Health & Medical News
IVD Antibody Development Services for ApoA, B, E Markers - Creative Biolabs
Cancers | Free Full-Text | Apolipoprotein A-I (ApoA-I), Immunity, Inflammation and Cancer
Determination of the number of apoA-I molecules in an A-I- POPC-97... | Download Scientific Diagram
Cells | Free Full-Text | Apolipoprotein A-IV: A Multifunctional Protein Involved in Protection against Atherosclerosis and Diabetes
Plasma levels of apolipoproteins C-III, A-IV, and E are independently associated with stable atherosclerotic cardiovascular disease - ScienceDirect
Abstract 15086: Associations Between Apolipoprotein A-I Proteoforms and Markers of Cardiometabolic Health | Circulation
Schematic presentation of ApoA-I peptide interaction with lipids. (A)... | Download Scientific Diagram
Paired Measurements of Paraoxonase 1 and Serum Amyloid A as Useful Disease Markers
HDL cholesterol efflux normalised to apoA-I is associated with future development of type 2 diabetes: from the CORDIOPREV trial | Scientific Reports